Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Mother's choice not to breast feed PC-05
Non Aneurysmal SAH Documentation CSTK-06
MER Eligibility CSTK
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
Arrival Time for STK, CSTK and STK-OP Measures STK
Patients transferred after t-PA STK
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
Reason for No VTE Prophylaxis STK, STK-01
Statin prescibed the day after discharge STK-06, STK-08
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
HBIPS-1 Timeframe for Screening Questions HBIPS
ABstraction for Date Last Known Well STK
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
Pneumonia diagnosis: ED/Direct Admint PN
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
STK-6 Data Entry in CMIP for Q1 2010 STK
CSTK-01 Procedures and Timing 1 calculation CSTK-01
First NIHSS performed days after admission CSTK-01
Stroke Education Documentation Examples STK-08
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
Pre-transfusion platelet count allowable value BM-04b
Data abstraction for VTE Prophylaxis when administered prior to admission STK
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
Rationale for Code Stroke Form as the Priority Data Source STK-4
HBIPS Event Dates Prior to Admission HBIPS
Psychiatic Care Setting -Patient Inclusion HBIPS
Late Coded Stroke STK-4 and STK-5 STK, STK-4
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
Can an addendum be added to the medical record? STK-01
CSTK4 documentation time? CSTK-04
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
Stroke VTE Prophylaxis STK-01
What should we do when conflicting or multiple times of last known well are documented? STK-04
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
Is intensive dosing of statin required to meet STK-6? STK
Written discharge instructions for warfarin therapy VTE-05
What is the Date and Time Last Known Well? STK-04
Referral to Next Level of Care HBIPS
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
Time NIHSS performed CSTK-01
Assessed for Rehabilitation STK
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
What terms can be used for Comfort Measures Only? STK
Time Last Known Well is after hospital arrival STK-04
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Will Primary Stroke Certification continue? STK
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
Last Known Well STK-04
Continuing Care Plan Document Questions HBIPS
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
Last known well when symptoms resolve then reoccur STK
Documentation for Rehabilitation Assessment STK-10
Activity specifics ACHF
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK
Admitted for elective carotid intervention STK
IV Alteplase STK-OP
STK-4 IV Thrombolytic Therapy STK
Support System ACHF
Why are there not more contraindications to vaginal deliveries? PC
Number of cases needed for submission BM
Why has this indicator has changed to include the word "elective"? STK
Stroke Module STK
How is Length of Stay (LOS calculated for STK-1?) STK-01
Risk of Violence to Self HBIPS, HBIPS-1
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
Definition of validated and non-validated screening tool for substance use SUB-01
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
Time Last Know Well -Stroke STK
TEDS for VTE Prophylaxis STK, STK-01
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
CSTK 4 Denominator Population CSTK-04
Clarification of data elements needed CSTK-05b, CSTK-07
Earliest principal procedure time/first pass time CSTK
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
NIHSS Timed After Discharge CSTK-01
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
Documentation for tPA exclusion STK, STK-04
Clarification of CSTK-1 Measure Population Requirements CSTK-01
Sampling when both STK and CSTK are collected by a HCO CSTK
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
NIHSS Score Clarification CSTK-01
Does the following documentation meet education regarding Risk factors for stroke? STK
Refusal of SCD's STK, STK-01
Procedures Performed During Hospitalization ACHF
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7
Is admission day counted as day 1 for STK-1? STK
Stroke Diagnosed Mid-Hospital Stay STK-5
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
Elective carotid intervention documentation STK
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
What would I document as Last Known Well? STK, STK-4
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
Continuing Care Plan - Reason for Hospitalization HBIPS
Documentation added to D/C summary after discharge STK-6
First Radiographic Image, CSTK 07 STK
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
Next Level of Care Provider Same as Hospital Provider HBIPS
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Exclusive breast milk feeding definition PC
Will Evidence of Atherosclerosis remain a data element? STK-06
Can I use VTE used during the Observation, given prior to hospital admission STK-1
Evidence of Atherosclerosis STK
Time of the teleneurology NIHSS CSTK-01
Graduated Compression Stocking (GCS) STK
Antithrombotic Administration after t-PA STK-05
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
Abstraction for Clinical Trial (STK ) STK
What is the Admission Date? STK
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
Documention of Stroke education at discharge, STK-08
Does all medical record documentation need to be dated and timed? STK
Time Last Known Well - Conflicting Physician Documentation STK-04
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
What is the Date and Time of Last Well Known? STK-04
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
Comprehensive Stroke (CSTK Sub-Populations) CSTK
Admission Date STK-01
Question regarding the new STK OP 1 Measure STK-OP
Follow-up to UserQuestion102705 CSTK
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
Stroke that occurs after admission CSTK
Importance of exclusive breast milk feeding PC
Transfer in patients that are intubated CSTK-01
Sampling Requirements for CSTK CSTK
Stroke Measure Requirements STK
PSC CSTK 01 population CSTK, CSTK-01
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
Hunt and Hess & ICH Score Documentation CSTK-03
Are patients that stroke while an inpatient included in the measure population? STK
Primary Stroke Certification and Transition to Stroke Core Measures STK
Reason for not giving Nimodipine within 24 hours CSTK
Sampling Requirements for CSTK CSTK
Statins at Discharge STK-06
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Elective Carotid Intervention STK
Documentation for Stroke Education HF-1
Procedure Time Inclusion Terms CSTK-03
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
Data Element- Violence Risk to Self HBIPS
Abstraction for Last Known Well STK-04
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Positive Brain Image CSTK
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Jan 2012 Follow-up monitoring VTE-05
NIHSS versus mNIHSS CSTK-05
Documentation of Stroke Education STK-08
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
Documentation of Last Known well STK, STK-4
Time Last Known Well STK
One Episode of Care and Thrombolytic Therapy Administration STK
Statin therapy for patients 75yrs and older STK
Retirement of STK-7 Dysphagia Screen STK-07
Birth Weight suggested Sources PC-06
MER Attempted During this Encounter - Clot Dissolved CSTK-11
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
Please submit all outpatient questions to QnetQuest.org OP
STK-5 Antithrombotic - LOVENOX SQ STK
Arrival time for transferred patients CSTK-07
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Who should perform mRS? CSTK-02
Assessed for Rehabaliitation Services STK-10
Questions about sampling? ACHF
Recommended ways to obtain mRS CSTK, CSTK-02
Stroke Measures STK-7 and STK-9 STK
STK-10 Assessed for Rehabilitation Services STK-10
Unable to Calculate LDL Value Due to High Triglycerides STK-06
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Covid Vaccine Audit HCSS
Triglyceride >400mg/dL STK
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
Patient Referral to Next Level of Care Provider HBIPS
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
doucumentation of ich and hunt hess CSTK-03
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
thyroid CA PC-01
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
Multiple TICI reperfusion grades CSTK-08
Last Known Well STK, STK-04
Follow-up to UserQuestionId03Stk100628 STK
Follow-up to UserQuestionId03Vte101043 VTE-05
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
What number should we enter for the denominator? HCSS-6
How do I determine my firm group? HCSS
Functional Status at Discharge ACHF
Multiple EMRs HBIPS
Multiple Procedure Times CSTK, CSTK-01
Code 433.10 and Transient Ischemic Attack STK
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
Pre-anemia screening BM
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
Reason for not prescribing antithrombotic therapy at hospital discharge STK
Which version of the specifications should be used for stroke data collection? STK
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
Procedure codes for HF outpatients ACHF
COVID-19 CSTK
CSTK Procedure Times CSTK
Why aren't more exclusions to elective delivery considered? PC
HBIPS Discharge Status HBIPS
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
Do I need to enter this data again or can I just start with January? HCSS
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
Can we use E/M code 99211? ACHF
Clairfy time to recanalization CSTK, CSTK-07
mRS CSTK
Sampling Methodology for Stroke STK
What constitutes a failed thrombectomy CSTK-11
Arrival time Abstraction. CSTK-11
Data Abstraction for "Last Known Well" STK
Follow-up to UserQuestionId03Stk100984 STK-04
Documentation Compliance for IV t-PA STK, STK-04
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
Rehabilitation Assessment STK
Dabigatran (PRADAXA use in Stroke Patients) STK
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
Date/Time of First Pass for CSTK-7 CSTK
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
SCIP questions related to the April 2010 manual SCIP
History of low vertical incision documented BUT no documentation of classical incision. PC-01
Pradaxa (dabigatran prescribed at discharge) STK-02
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
SUB 2 SUB
DVT Prophylaxis and Ambulation STK, STK-01
STK-6 "Evidence of Atherosclerosis" STK
ICD-9-CM Code 433.10 STK
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
Stroke core measure data for PSC hospitals STK
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Date Last Known Well STK
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
CSTK 3 CSTK, CSTK-03
Define who is considered a stroke team for STK 4. STK
Reason for Not Initiating IV Thrombolytic STK
Comparative Data for Stroke Measures STK
Abstraction Tools ASR-OP-1
HBIPS- Restraint and Seclusion in ED HBIPS-3
Reason for Not Administering Antithrombotic Therapy? STK
Numerator Statement HCSS
Inter-rater Reliability and Chart Re-asbstraction STK
Last Known Well Version 5.2 STK-4
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Expired after discharge CSTK-02
Need information about the required import file specifications BM
Positive over negative findings STK-OP
Discharged on Anticoagulation Therapy STK
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
Is this considered a stroke clinical trial patient? STK
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
Discharge Code and Transfers of Patients STK-OP
Patient Ambulatory At End of Hospital Day 2 STK
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
What value should be selected when VTE prophylaxis is administered several days after admission? STK
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04
Reason for extending IV tPA STK-4
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
NIHSS time STK
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
STK 10 Assessed for rehabilitation STK-10
activity charting ACHF
Patient Population CSTK
How to abstact Last Known Well when there is too much information? STK
Failed attempt at thrombectomy CSTK-08
ICH score documentation CSTK-03b
Optimal Medication Management ACHF
Last Known Well Y/N? STK-4

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine